US medical giants say Australia’s Pharmaceutical Benefits Scheme is an “egregious and discriminatory” program that Trump should target in the next wave of tariffs.
Disclaimer: The article linked is from a single source with a single perspective. Make sure to cross-check information against multiple sources to get a comprehensive view on the situation.
It sounds like the single payer system in Australia saves its citizens money by negotiating competitive rates, and US drug companies don’t like that they can’t extort them like they can US patients.
Yeah that’s what I was thinking. Insulin costs $7 in Australia vs $98 in the US. I’m guessing US drug companies want the cost in Australia to go up so US doesn’t look as bad in comparison
its per vial to, besides that the slow, delayed and fast release insulin are more expensive too.